Physician profile
Keith C Soderberg
NPI 1770531527
$1,686.52
in general payments reported to CMS, 2019-2025
18 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $81.32 · 2021: $348 · 2022: $377 · 2023: $133 · 2024: $298 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.67 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $396.21 | 2021-2025 | Dupixent |
| Genzyme Corporation | $208.44 | 2020-2025 | |
| Optinose US, INC. | $202.73 | 2020-2022 | |
| Glaxosmithkline, LLC. | $197.45 | 2022-2025 | Nucala |
| Stryker Corporation | $182.48 | 2019-2022 | |
| Aerin Medical INC. | $132.21 | 2022 | |
| Amgen INC. | $66.00 | 2022-2025 | |
| Carestream Dental, LLC | $62.44 | 2019 | |
| Acclarent, INC | $61.76 | 2021 | |
| Phadia US INC. | $35.30 | 2021-2024 | Immunocap |
| Takeda Pharmaceuticals U.S.A., INC. | $32.26 | 2022 | |
| Intersect Ent, INC. | $18.26 | 2020 | |
| Kaleo, INC. | $17.67 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $17.05 | 2025 | Neffy |
| Smith+Nephew, INC. | $16.93 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $13.80 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $12.82 | 2022 | |
| Medtronic, INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Soderberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.